We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+0.46%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$4.05B
AUM Growth
-$550M
Cap. Flow
-$529M
Cap. Flow %
-13.06%
Top 10 Hldgs %
85.4%
Holding
87
New
24
Increased
17
Reduced
17
Closed
9

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$401M
2
VIPS icon
Vipshop
VIPS
+$232M
3
NTES icon
NetEase
NTES
+$118M
4
TCOM icon
Trip.com Group
TCOM
+$70.5M
5
FUTU icon
Futu Holdings
FUTU
+$48.4M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$393M
2
MSFT icon
Microsoft
MSFT
+$283M
3
AMD icon
Advanced Micro Devices
AMD
+$165M
4
AMZN icon
Amazon
AMZN
+$144M
5
TTWO icon
Take-Two Interactive
TTWO
+$116M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 47.59%
2 Healthcare 33.8%
3 Real Estate 8.09%
4 Communication Services 4.98%
5 Technology 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PDD icon
1
Pinduoduo
PDD
$124B
$1.18B 29.16%
8,892,447
-2,899,100
-25% -$393M
ONC
2
BeOne Medicines Ltd
ONC
$34B
$739M 18.22%
5,176,906
– –
BABA icon
3
Alibaba
BABA
$275B
$387M 9.55%
5,379,448
+5,235,548
+3,638% +$401M
BEKE icon
4
KE Holdings
BEKE
$17.7B
$328M 8.09%
23,172,330
-6,009,538
-21% -$94.1M
LEGN icon
5
Legend Biotech
LEGN
$3.67B
$294M 7.25%
6,636,496
+651,946
+11% +$30.1M
VIPS icon
6
Vipshop
VIPS
$7.18B
$193M 4.76%
14,806,000
+14,607,400
+7,355% +$232M
NTES icon
7
NetEase
NTES
$82.9B
$132M 3.27%
1,385,814
+1,236,114
+826% +$118M
AVBP icon
8
ArriVent BioPharma
AVBP
$1.4B
$83.2M 2.05%
4,484,672
+555,555
+14% +$9.91M
TCOM icon
9
Trip.com Group
TCOM
$29.4B
$65.1M 1.61%
+1,384,642
New +$70.5M
KNSA icon
10
Kiniksa Pharmaceuticals
KNSA
$6.07B
$58.7M 1.45%
3,144,556
+8,821
+0.3% +$165K
FUTU icon
11
Futu Holdings
FUTU
$14.4B
$47M 1.16%
+716,089
New +$48.4M
ENFN
12
DELISTED
Enfusion, Inc.
ENFN
$42.4M 1.05%
4,975,183
– –
CTKB icon
13
Cytek Biosciences
CTKB
$576M
$37.1M 0.92%
6,657,030
– –
BBIO icon
14
BridgeBio Pharma
BBIO
$16.6B
$35.2M 0.87%
1,390,653
+23,164
+2% +$633K
DHR icon
15
Danaher
DHR
$142B
$27.2M 0.67%
108,700
-362,400
-77% -$91.6M
DASH icon
16
DoorDash
DASH
$85.9B
$27M 0.67%
247,912
-335,551
-58% -$40.4M
CRM icon
17
Salesforce
CRM
$151B
$24.8M 0.61%
96,358
-365,779
-79% -$97.9M
META icon
18
Meta Platforms (Facebook)
META
$1.5T
$22.4M 0.55%
44,476
+38,476
+641% +$18.7M
AZN icon
19
AstraZeneca
AZN
$271B
$21.2M 0.52%
+135,875
New +$20.4M
HTHT icon
20
Huazhu Hotels Group
HTHT
$13.3B
$18.9M 0.47%
568,613
-367,307
-39% -$13.9M
YSG
21
Yatsen Holding
YSG
$314M
$18.6M 0.46%
6,987,839
– –
APP icon
22
Applovin
APP
$137B
$18.2M 0.45%
218,400
+87,600
+67% +$6.8M
ONON icon
23
On Holding
ONON
$12.4B
$16M 0.39%
411,400
– –
GOOG icon
24
Alphabet (Google) Class C
GOOG
$4.05T
$12.8M 0.32%
69,724
+10,824
+18% +$1.84M
GERN icon
25
Geron
GERN
$911M
$12.7M 0.31%
+2,990,500
New +$11.7M
1
2 3 4

Similar funds

TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

HHLR Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, HHLR Advisors held 87 positions worth $4.05B, down 12% from $4.6B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

HHLR Advisors withdrew a net $529M in Q2 2024, closing 9 positions and reducing 17 holdings. Its most notable exit was Advanced Micro Devices, an estimated $165M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 48% of assets, up from 37% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, HHLR Advisors opened a new position in Trip.com Group worth $65.1M.

  • HHLR Advisors's largest Q2 2024 buy was Trip.com Group: 1,384,642 shares worth $65.1M.
  • HHLR Advisors added most to Alibaba in Q2 2024, an estimated $401M increase.
  • HHLR Advisors's biggest Q2 2024 reduction was Pinduoduo, cutting an estimated $393M.
  • HHLR Advisors fully exited Advanced Micro Devices in Q2 2024, selling an estimated $165M.
  • HHLR Advisors's ten largest holdings make up 85% of its $4.05B portfolio in Q2 2024.
  • HHLR Advisors opened 24 new positions and closed 9 in Q2 2024.
  • HHLR Advisors's portfolio value fell 12% quarter-over-quarter to $4.05B.

Based on HHLR Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.